Welcome to our dedicated page for Allstar Health Brands news (Ticker: ALST), a resource for investors and traders seeking the latest updates and insights on Allstar Health Brands stock.
AllStar Health Brands Inc (ALST) delivers innovative healthcare solutions and strategic sports investments across global markets. This news hub provides investors and stakeholders with essential updates on corporate developments, financial milestones, and growth initiatives.
Key coverage areas include earnings reports, mergers & acquisitions (notably soccer club negotiations in Italy), new product launches in nutritional supplements, and progress on stadium development projects. Users gain insights into both healthcare operations and emerging sports ventures through verified press releases and objective reporting.
Bookmark this page to efficiently track ALST's cross-sector strategies, including partnerships with M&A specialists like MergersCorp and community-focused athletic programs. Regular updates ensure informed analysis of the company's unique position at the intersection of healthcare innovation and sports industry expansion.
AllStar Health Brands (ALST) has signed a Letter of Intent to acquire 25% of Advent Galaxy Inc. for $15 million in Preferred Series B shares valued at $10 each. This investment positions AllStar to enter the metaverse and augmented/virtual reality sectors, with Advent Galaxy's ADVENT MEGA MALL project as a focal point. AllStar has an option to acquire an additional 25% for $20 million within two years. The move aims to expand AllStar's technological footprint while enhancing shareholder value through new market avenues.
AllStar Health Brands (ALST) has secured purchase orders to distribute gummy products, marking a significant step in its product launch strategy. The company will simultaneously develop a dedicated website and execute a comprehensive marketing campaign to boost product awareness. Chairman Richard Goulding emphasized the unique benefits of their offerings, including Sleepy Watermelon, Relief Raspberry, and Calming Mango. Distribution will leverage existing networks, including pharmacies and convenience stores, as AllStar aims to meet demand and educate consumers on the efficacy of its products.
AllStar Health Brands (OTC Pink: ALST) announced a strategic partnership with Virotek Biosciences Inc. to provide rapid COVID testing services to various commercial and civic clients. This initiative caters to employers looking for alternatives to mandatory vaccinations. Additionally, ALST is in the testing phase of a new website and has secured a supply chain for its products, anticipating rapid order fulfillment in the coming days. The company's CEO, Pete Wanner, expressed optimism about the upcoming product launches, leveraging established distribution networks for health equipment and nutraceutical products.
AllStar Health Brands (OTC Pink: ALST) has partnered with Gold River Productions, Inc. to distribute a new line of high-grade CBD gummies, catering to specific consumer health needs, starting in Jamaica and Florida. CEO Pete Wanner expressed excitement over the partnership, emphasizing the unique formulation of Gold River's products. The collaboration aims to leverage existing distribution networks across North America and beyond, addressing pent-up market demand. This venture marks a significant step in expanding AllStar's reach into the nutraceutical sector.
AllStar Health Brands Inc. (OTC Pink: ALST) announces a leadership change as Dr. Peter D. Bagi steps down as CEO to focus on medical research. Peter Wanner, the current CFO with over 30 years of experience, will take over as CEO. The company is pivoting towards COVID-19 testing and vaccine distribution in underserved markets, anticipating revenue from international operations. Wanner emphasized the urgency of addressing the needs created by the Delta variant's surge and aims to develop a pipeline of products to meet demand.
AllStar Health Brands Inc. (OTC PINK:ALST) announced its initial order delivery of equipment and test kits to Apogee Pharmaceuticals on October 15, 2020. President Dr. Daniel Bagi expressed optimism for future orders, highlighting the growing demand for Covid-19 testing as the economy reopens. AllStar offers various testing solutions, including Point-of-Care Antibody and PCR tests, with an antigen test expected soon. Established in 2017, AllStar aims to innovate healthcare products across the Americas and Europe.
AllStar Health Brands Inc. (ALST) has entered advanced negotiations in Florida to deploy up to three QuikLAB mobile testing units. These units are capable of conducting thousands of tests daily, delivering antibody results within minutes and PCR results in under two hours. The mobile units aim to reduce Covid-19 transmission risks by operating outside retail locations. AllStar plans to supply additional antibody and PCR test kits alongside these units, enhancing their healthcare offerings.
AllStar Health Brands Inc. (OTCPINK:ALST) announced its initial order for a PCR machine from CO-Diagnostics Inc. This order is part of a program to incorporate CO-Diagnostics' LOGIX Smart TM COVID-19 kits. President Dr. Daniel Bagi highlighted the rising COVID-19 infection rates and the corresponding demand for testing. He emphasized the advantages of the CODX system, including increased accuracy and rapid results, making it suitable for decentralized testing.
AllStar Health Brands Inc. (OTC Markets:ALST) has entered a Partnership Agreement with an eCommerce Group to enhance its Sales and Marketing capabilities. This strategic move aims to integrate AllStar's high-value health products into the partner's existing infrastructure, which includes merchant processing and digital marketing services. Dr. Daniel Bagi, President, expressed that this collaboration could significantly boost revenue and profit margins in underserved health markets, particularly in Women’s Health. AllStar is dedicated to improving health through innovative products.
AllStar Health Brands Inc. (OTC PINK:ALST) announced it is in discussions to acquire a revenue-generating company based in the Northeast US, specializing in health supplements targeting diabetes and weight management. These conditions are linked to heightened risks of Covid-19, making the acquisition strategically significant for AllStar's growth. The company aims to expand the distribution of these products across the US and potentially in other Americas. Additionally, AllStar is actively marketing Covid-19 rapid antibody tests and QuikLAB testing modules.